Open Access
Med Sci (Paris)
Volume 35, Number 12, Décembre 2019
Anticorps monoclonaux en thérapeutique
Page(s) 1213 - 1215
Section Le Magazine
Published online 06 January 2020
  1. Kral A, O’Donoghue GM. Profound deafness in childhood. N Engl J Med 2010 ; 363: 1438–1450. [Google Scholar]
  2. Duman D, Tekin M. Autosomal recessive nonsyndromic deafness genes: a review. Front Biosci 2012 ; 17: 2213–2236. [Google Scholar]
  3. Vivero RJ, Fan K, Angeli S, et al. Cochlear implantation in common forms of genetic deafness. Int J Pediatr Otorhinolaryngol 2010 ; 74: 1107–1112. [CrossRef] [PubMed] [Google Scholar]
  4. Mingozzi F, High KA. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet 2011 ; 12: 341–355. [CrossRef] [PubMed] [Google Scholar]
  5. Minoda R, Miwa T, Ise M, Takeda H. Potential treatments for genetic hearing loss in humans: current conundrums. Gene Ther 2015 ; 22: 603–609. [CrossRef] [PubMed] [Google Scholar]
  6. Hepper PG, Shahidullah BS. Development of fetal hearing. Arch Dis Child 1994 ; 71: F81–F87. [CrossRef] [PubMed] [Google Scholar]
  7. Yasunaga S, Grati M, Cohen-Salmon M, et al. A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness. Nat Genet 1999 ; 21: 363–369. [Google Scholar]
  8. Roux I, Safieddine S, Nouvian R, et al. Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse. Cell 2006 ; 127: 277–289. [CrossRef] [PubMed] [Google Scholar]
  9. Akil O, Dyka F, Calvet C, et al. Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model. Proc Natl Acad Sci USA 2019 ; 116: 4496–4501. [CrossRef] [Google Scholar]
  10. Ghosh A, Yue Y, Duan D. Efficient transgene reconstitution with hybrid dual AAV vectors carrying the minimized bridging sequences. Hum Gene Ther 2011 ; 22: 77–83. [Google Scholar]
  11. Bouccara D, Avan P, Mosnier I. Réhabilitation auditive. Med Sci (Paris) 2005 ; 21: 190–197. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  12. Hardelin JP, Denoyelle F, Levilliers J, et al. Les surdités héréditaires: génétique moléculaire. Med Sci (Paris) 2004; 20: 311–6. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  13. Meyer A, Petit C, Safieddine S. Thérapie génique des surdités héréditaires: défis et promesses. Med Sci (Paris) 2013 ; 29: 883–889. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  14. Calvet C, Lahlou G, Safieddine S. Progrès de la thérapie génique: espoirs pour le syndrome d’Usher. Med Sci (Paris) 2018 ; 34: 842–848. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.